Pristiq Extended-Release 00008-1222-01
Generic: Desvenlafaxine Succinate
- Manufacturer
- Wyeth Pharmaceuticals Llc, A Subsidiary Of Pfizer Inc.
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Prescription Drug
- Marketing Start
- May 1, 2008
- Listing Expires
- December 31, 2027
- Application
- NDA021992
Need to source Pristiq Extended-Release? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Desvenlafaxine Succinate | 100 mg/1 |
Drug Class
Cytochrome P450 2D6 Inhibitors [MoA]Norepinephrine Uptake Inhibitors [MoA]Serotonin Uptake Inhibitors [MoA]
Selected Package
00008-1222-01Selected90 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-01)
Other packages for this product(3)
14 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-14)
30 TABLET, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0008-1222-30)
100 BLISTER PACK in 1 CARTON (0008-1222-50) / 1 TABLET, EXTENDED RELEASE in 1 BLISTER PACK